期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

糖尿病与甲状腺疾病关系的研究进展 被引量：34

原文传递
导出
摘要 糖尿病患者可有除胰岛素外的多种激素分泌异常，有的激素可能作为病因参与糖尿病的发病过程，甲状腺激素（TH）是其中之一。本文就甲状腺疾病对糖尿病发生发展的影响综述如下。
作者 张妮娅 刘超
机构地区 南京医科大学附属淮安第一医院内分泌科 南京医科大学第一附属医院内分泌科
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第7期558-560,共3页 Chinese Journal of Diabetes
关键词 糖尿病 甲状腺疾病 甲状腺功能 发病机制
分类号 R587.1 [医药卫生—内分泌] R581 [医药卫生—内分泌]
  • 相关文献

参考文献3

  • 1Aspasia S Soultati,Spyridon P Dourakis,Alexandra Alexopoulou,Melanie Deutsch,Athanasios J Archimandritis.Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C[J].World Journal of Gastroenterology,2007,13(8):1292-1294. 被引量：15
  • 2J. M. M. Howson,D. B. Dunger,S. Nutland,H. Stevens,L. S. Wicker,J. A. Todd. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene[J] 2007,Diabetologia(4):741～746
  • 3A. M. Hennige,V. Strack,E. Metzinger,G. Seipke,H.-U. H?ring,M. Kellerer. Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors[J] 2005,Diabetologia(9):1891～1897

二级参考文献30

  • 1[1]Okanoue T,Sakamoto S,Itoh Y,Minami M,Yasui K,Sakamoto M,Nishioji K,Katagishi T,Nakagawa Y,Tada H,Sawa Y,Mizuno M,Kagawa K,Kashima K.Side effects of high-dose interferon therapy for chronic hepatitis C.J Hepatol 1996; 25:283-291
  • 2[2]Fattovich G,Giustina G,Favarato S,Ruol A.A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.J Hepatol 1996; 24:38-47
  • 3[3]Deutsch M,Dourakis S,Manesis EK,Gioustozi A,Hess G,Horsch A,Hadziyannis S.Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.Hepatology 1997; 26:206-210
  • 4[4]Mandac JC,Chaudhry S,Sherman KE,Tomer Y.The clinical and physiological spectrum of interferon-alpha induced thyroiditis:toward a new classification.Hepatology 2006; 43:661-672
  • 5[5]Fabris P,Floreani A,Tositti G,Vergani D,De Lalla F,Betterle C.Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.Aliment Pharmacol Ther 2003; 18:549-558
  • 6[6]Maede Y,Morishita K,Iwamura K,Takayama Y,Tsukada Y,Kishino M,Shimizu T,Matsushima S,Komatsu T,Kasagi Y.Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a.Nippon Naika Gakkai Zasshi 2005; 94:2600-2602
  • 7[7]Ishak K,Baptista A,Bianchi L,Callea F,De Groote J,Gudat F,Denk H,Desmet V,Korb G,MacSween RN.Histological grading and staging of chronic hepatitis.J Hepatol 1995; 22:696-699
  • 8[8]Koivisto VA,Pelkonen R,Cantell K.Effect of interferon on glucose tolerance and insulin sensitivity.Diabetes 1989; 38:641-647
  • 9[9]Ishigami Y,Kanda T,Wada M,Shimizu Y.Glucose intolerance during interferon therapy in patients with chronic hepatitis type C.Nippon Rinsho 1994; 52:1901-1904
  • 10[10]Imano E,Kanda T,Ishigami Y,Kubota M,Ikeda M,Matsuhisa M,Kawamori R,Yamasaki Y.Interferon induces insulin resistance in patients with chronic active hepatitis C.J Hepatol 1998; 28:189-193

共引文献14

同被引文献302

引证文献34

二级引证文献227

中国糖尿病杂志
2009年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部